The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD

医学 痛风 肾脏疾病 尿酸 肾功能 内科学 高尿酸血症 随机对照试验 重症监护医学 临床试验
作者
Yuka Sato,Daniel I. Feig,Austin G. Stack,Duk‐Hee Kang,Miguel Angel Lanaspa,Ahsan A. Ejaz,Laura Gabriela Sánchez‐Lozada,Masanari Kuwabara,Claudio Borghi,Richard J. Johnson
出处
期刊:Nature Reviews Nephrology [Nature Portfolio]
卷期号:15 (12): 767-775 被引量:209
标识
DOI:10.1038/s41581-019-0174-z
摘要

Hyperuricaemia is common among patients with chronic kidney disease (CKD), and increases in severity with the deterioration of kidney function. Although existing guidelines for CKD management do not recommend testing for or treatment of hyperuricaemia in the absence of a diagnosis of gout or urate nephrolithiasis, an emerging body of evidence supports a direct causal relationship between serum urate levels and the development of CKD. Here, we review randomized clinical trials that have evaluated the effect of urate-lowering therapy (ULT) on the rate of CKD progression. Among trials in which individuals in the control arm experienced progressive deterioration of kidney function (which we define as ≥4 ml/min/1.73 m² over the course of the study — typically 6 months to 2 years), treatment with ULT conferred consistent clinical benefits. In contrast, among trials where clinical progression was not observed in the control arm, treatment with ULT was ineffective, but this finding should not be used as an argument against the use of uric acid-lowering therapy. Although additional studies are needed to identify threshold values of serum urate for treatment initiation and to confirm optimal target levels, we believe that sufficient evidence exists to recommend routine measurement of serum urate levels in patients with CKD and consider initiation of ULT among those who are hyperuricaemic with evidence of deteriorating renal function, unless specific contraindications exist. This Perspectives article considers why clinical trials of urate-lowering therapy (ULT) have shown inconsistent renoprotective effects in patients with chronic kidney disease, and suggests that sufficient evidence exists to support the use of routine screening for hyperuricaemia and initiation of ULT in selected patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1111111发布了新的文献求助10
刚刚
完美世界的应助被雯雯采纳,获得10
1秒前
1秒前
回望发布了新的文献求助10
1秒前
1秒前
2秒前
StarsFX发布了新的文献求助10
2秒前
刘佳琪发布了新的文献求助10
2秒前
2秒前
3秒前
3秒前
3秒前
可册册完成签到,获得积分10
3秒前
Catherine发布了新的文献求助10
4秒前
4秒前
笙笙发布了新的文献求助10
5秒前
笙笙发布了新的文献求助10
5秒前
5秒前
华仔的应助被三分之二采纳,获得10
5秒前
5秒前
syvshc的应助被parantal采纳,获得10
6秒前
Orange的应助被晟觞采纳,获得10
6秒前
6秒前
6秒前
7秒前
可爱的函函的应助被XIXIHAHA采纳,获得10
7秒前
Grace完成签到,获得积分10
7秒前
7秒前
7秒前
笙笙发布了新的文献求助10
7秒前
ethyl完成签到 ,获得积分10
8秒前
8秒前
情怀的应助被西陆采纳,获得10
8秒前
明理的千筹完成签到,获得积分10
8秒前
8秒前
笙笙发布了新的文献求助10
8秒前
笙笙发布了新的文献求助30
8秒前
笙笙发布了新的文献求助10
8秒前
笙笙发布了新的文献求助100
8秒前
笙笙发布了新的文献求助10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177767
求助须知:如何正确求助?哪些是违规求助? 9568590
关于积分的说明 21799821
捐赠科研通 7772374
什么是DOI,文献DOI怎么找? 3432476
关于科研通互助平台的介绍 2556695
邀请新用户注册赠送积分活动 2478034